The $1000 Pill: Pharma's Price Gouging
Insulin costs $10 to make. Why are you paying so much? The patent game explained.
Opioid Crisis Settlement
Vaccine Immunity Deals
The contradiction: Paid billions for causing addiction, demanded total immunity for new shots.
Current patent laws allow companies to make minor tweaks to old drugs ('evergreening') to extend monopolies for decades.
The core record has 3 important points: 3 companies control 90% of the insulin market. US prices are 10x higher than Canada for the same drug. Marketing budgets often exceed R&D budgets.
Ownership context: Agro-Chemical Giants (Monsanto/Bayer). Funding context: Top 3 Lobbying Spender in DC.
The source trail for this page includes Patent Office Database and OpenSecrets Lobbying Data.
Summary
Current patent laws allow companies to make minor tweaks to old drugs ('evergreening') to extend monopolies for decades.
⚡ Key Facts
- 3 companies control 90% of the insulin market.
- US prices are 10x higher than Canada for the same drug.
- Marketing budgets often exceed R&D budgets.
The $1000 Pill: Pharma's Price Gouging
Paid billions for causing addiction, demanded total immunity for new shots.
Network of Influence
See how the story connects.
Select any actor or numbered connection, then inspect the evidence before drawing a conclusion.
Big Pharma Revolving Door FDA
Follow the public record
Source Trail
Primary records and direct statements
Independent reporting and analysis
Get the next investigation in your inbox
One email a week. Receipts only. Free.
Free. Unsubscribe anytime. We never share your email.
